Literature DB >> 3107992

Mechanisms of anticonvulsant drug action. I. Drugs primarily used for generalized tonic-clonic and partial epilepsies.

C L Faingold, R A Browning.   

Abstract

The mechanisms by which the clinically effective anticonvulsant drugs act include effects on neurotransmitter action, effects on repetitive neuronal firing mechanisms, effects on neuronal networks, and effects on neuronal ionic transport. The combination of effects possessed by each individual agent along with its pharmacokinetic properties determine the usefulness of each agent. Phenytoin, carbamazepine and phenobarbital are effective in generalized tonic-clonic and partial epilepsies. Phenytoin exerts important effects on neuronal sodium and calcium ion transport, reduces repetitive firing, reduces excitation in neuronal networks of the brainstem reticular formation, and produces some decrease in the effect of the inhibitory transmitter, gamma-aminobutyric acid (GABA). Carbamazepine blocks repetitive firing mechanisms, reduces excitation in neuronal networks with some effect on sodium and potassium ion transport, and has effects on the actions of norepinephrine, adenosine and perhaps acetylcholine. Phenobarbital enhances the action of GABA with some reduction of repetitive firing and reduces excitation in reticular formation neuronal networks.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3107992     DOI: 10.1007/bf00647273

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  54 in total

1.  Diphenylhydantoin: excitability reducing action in single myelinated nerve fibres.

Authors:  J R Schwarz; W Vogel
Journal:  Eur J Pharmacol       Date:  1977-08-01       Impact factor: 4.432

2.  Effects of anticonvulsant drugs on nerve terminals.

Authors:  A Raines; F G Standaert
Journal:  Epilepsia       Date:  1969-06       Impact factor: 5.864

3.  Inhibition of amino acid transmitter release from rat brain slices by phenytoin and related anticonvulsants.

Authors:  J H Skerritt; G A Johnston
Journal:  Clin Exp Pharmacol Physiol       Date:  1983 Sep-Oct       Impact factor: 2.557

4.  Depression of synaptic transmission by diphenylhydantoin.

Authors:  Y Yaari; J H Pincus; Z Argov
Journal:  Ann Neurol       Date:  1977-04       Impact factor: 10.422

5.  Anticonvulsant drug mechanisms. Phenytoin, phenobarbital, and ethosuximide and calcium flux in isolated presynaptic endings.

Authors:  R S Sohn; J A Ferrendelli
Journal:  Arch Neurol       Date:  1976-09

6.  Neurotransmitter abnormalities in genetically epileptic rodents.

Authors:  H E Laird; J W Dailey; P C Jobe
Journal:  Fed Proc       Date:  1984-07

7.  Anticonvulsant drugs and the genetically epilepsy-prone rat.

Authors:  J W Dailey; P C Jobe
Journal:  Fed Proc       Date:  1985-07

8.  A pharmacological study in the kindling model of epilepsy.

Authors:  T E Albertson; R M Joy; L G Stark
Journal:  Neuropharmacology       Date:  1984-10       Impact factor: 5.250

9.  Interactions of the anticonvulsant carbamazepine with adenosine receptors. 1. Neurochemical studies.

Authors:  J H Skerritt; L P Davies; G A Johnston
Journal:  Epilepsia       Date:  1983-10       Impact factor: 5.864

Review 10.  Core mechanisms in generalized convulsions.

Authors:  W M Burnham
Journal:  Fed Proc       Date:  1985-05
View more
  2 in total

Review 1.  The role of the brain stem in generalized epileptic seizures.

Authors:  C L Faingold
Journal:  Metab Brain Dis       Date:  1987-06       Impact factor: 3.584

Review 2.  Carbamazepine toxicity and poisoning. Incidence, clinical features and management.

Authors:  L Durelli; U Massazza; R Cavallo
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.